Since we have previously reported an effect of the APOE genotype on IAPP-autoantibody levels in AD patients, we also investigated if plasma IAPPO-IgA levels in T2D patients are dependent on APOE4 status. This evidence concerns the gene CD79A and type 2 diabetes mellitus.